Nymox PharmaceuticalNYMXF
13F holders, Q2 2024 (June 30)1holders −2
0new positions
1sold out
$0.19avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Nymox Pharmaceutical Corp. (NYMXF) in their 13F filings, down 2 from Q1 2024. 0 opened new positions and 1 sold out. The largest holder was First Citizens Financial Corp ($7K).
- Company
- Nymox Pharmaceutical Corp.
- CUSIP
- P73398102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $30K |
All 13F filers, Q1 2024 → Q2 2024: 75,000 shares sold, net −75,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| First Citizens Financial Corp | 0.00% | No change | 35,100 | $7K |
"% of holder's portfolio" is NYMXF's weight in each manager's 13F, not the share of Nymox Pharmaceutical Corp. the manager owns.